Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Nara K, Yamamoto T, Yamashita H, Yagi K, et al. Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab the BMC Cancer 2023;23:979.
PMID: 37833660


Privacy Policy